References(30)
[1]
J. A. Harris and F. G. Benedict, A biometric study of human basal metabolism, Proc. Natl. Acad. Sci. USA, vol. 4, no. 12, pp. 370-373, 1918.
[2]
L. Cheng, H. X. Yang, H. Q. Zhao, X. Y. Pei, H. B. Shi, J. Sun, Y. P. Zhang, Z. Z. Wang, and M. Zhou, MetSigDis: A manually curated resource for the metabolic signatures of diseases, Brief. Bioinform., vol. 20, no. 1, pp. 203-209, 2019.
[3]
Y. M. Chen, Y. Liu, R. F. Zhou, X. L. Chen, C. Wang, X. Y. Tan, L. J. Wang, R. D. Zheng, H. W. Zhang, W. H. Ling, et al., Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults, Sci. Rep., vol. 6, no. 1, p. 19076, 2016.
[4]
D. Y. Hui, Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease, Curr. Opin. Lipidol., vol. 27, no. 5, pp. 507-512, 2016.
[5]
E. T. Oni, R. Kalathiya, E. C. Aneni, S. S. Martin, M. J. Blaha, T. Feldman, A. S. Agatston, R. S. Blumenthal, R. D. Conceiçao, J. A. M. Carvalho, et al., Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk, Am.J. Cardiol., vol. 115, no. 1, pp. 34-39, 2015.
[6]
A. Budhu, A. Terunuma, G. Zhang, S. P. Hussain, S. Ambs, and X. W. Wang, Metabolic profiles are principally different between cancers of the liver, pancreas and breast, Int.J. Biol. Sci., vol. 10, no. 9, pp. 966-972, 2014.
[7]
R. A. Moats, T. Ernst, T. K. Shonk, and B. D. Ross, Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease, Magn. Reson. Med., vol. 32, no. 1, pp. 110-115, 1994.
[8]
P. G. Unschuld, R. A. E. Edden, A. Carass, X. Y. Liu, M. Shanahan, X. Wang, K. Oishi, J. Brandt, S. S. Bassett, G. W. Redgrave, et al., Brain metabolite alterations and cognitive dysfunction in early Huntington’s disease, Mov. Disord., vol. 27, no. 7, pp. 895-902, 2012.
[9]
S. Hori, S. Nishiumi, K. Kobayashi, M. Shinohara, Y. Hatakeyama, Y. Kotani, N. Hatano, Y. Maniwa, W. Nishio, T. Bamba, et al., A metabolomic approach to lung cancer, Lung Cancer, vol. 74, no. 2, pp. 284-292, 2011.
[10]
C. Cheng, S. M. Zhuo, B. Zhang, X. Zhao, Y. Liu, C. L. Liao, J. Quan, Z. Z. Li, A. M. Bode, Y. Cao, et al., Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer, Int.J. Biol. Sci., vol. 15, no. 8, pp. 1654-1663, 2019.
[11]
Y. J. Xu, H. X. Yang, T. Wu, Q. Dong, Z. G. Sun, D. S. Shang, F. Li, Y. Q. Xu, F. Su, and S. Y. Liu, BioM2MetDisease: A manually curated database for associations between microRNAs, metabolites, small molecules and metabolic diseases, Database, vol. 2017, p. bax037, 2017.
[12]
D. S. Wishart, Y. D. Feunang, A. Marcu, A. C. Guo, K. Liang, R. Vázquez-Fresno, T. Sajed, D. Johnson, C. Li, N. Karu, et al., HMDB 4.0: The human metabolome database for 2018, Nucleic Acids Res., vol. 46, no. D1, pp. D608-D617, 2018.
[13]
D. S. Shang, C. Q. Li, Q. L. Yao, H. X. Yang, Y. J. Xu, J. W. Han, J. Li, F. Su, Y. P. Zhang, C. L. Zhang, et al., Prioritizing candidate disease metabolites based on global functional relationships between metabolites in the context of metabolic pathways, PLoS One, vol. 9, no. 8, p. e104934, 2014.
[14]
Y. Hu, T. Y. Zhao, N. Y. Zhang, T. Y. Zang, J. Zhang, and L. Cheng, Identifying diseases-related metabolites using random walk, BMC Bioinformatics, vol. 19, no. S5, p. 116, 2018
[15]
Y. T. Wang, L. R. Juan, J. J. Peng, T. Y. Zang, and Y. D. Wang, Prioritizing candidate diseases-related metabolites based on literature and functional similarity, BMC Bioinformatics, vol. 20, no. 18, p. 574, 2019.
[16]
Y. J. Qi, Random forest for bioinformatics, in Ensemble Machine Learning: Methods and Applications, C. Zhang and Y. Q. Ma, eds. Boston, MA, USA: Springer, 2012, pp. 307-323.
[17]
C. Chen, A. Liaw, and L. Breiman, Using Random Forest to Learn Imbalanced Data, Berkeley, CA, USA: University of California, 2004.
[18]
H. J. Lowe and G. O. Barnett, Understanding and using the medical subject headings (MeSH) vocabulary to perform literature searches, JAMA, vol. 271, no. 14, pp. 1103-1108, 1994.
[19]
Z. Q. Fang and X. J. Lei, Prediction of miRNA-circRNA associations based on k-NN multi-label with random walk restart on a heterogeneous network, Big Data Mining and Analytics, vol. 2, no. 4, pp. 261-272, 2019.
[20]
X. Y. Li, Y. P. Lin, C. L. Gu, and J. L. Yang, FCMDAP: Using miRNA family and cluster information to improve the prediction accuracy of disease related miRNAs, BMC Syst. Biol., vol. 13, no. 2, p. 26, 2019.
[21]
B. Perozzi, R. Al-Rfou, and S. Skiena, DeepWalk: Online learning of social representations, in Proc. 20th ACM SIGKDD Int. Conf. on Knowledge Discovery and Data Mining, New York, NY, USA, 2014, pp. 701-710.
[23]
A. Liaw and M. Wiener, Classification and regression by randomForest, R News, vol. 2, no. 3, pp. 18-22, 2002.
[24]
W. Jiang, J. Y. Lin, H. Q. Wang, and S. C. Zou. Hybrid semantic service matchmaking method based on a random forest, Tsinghua Sci. Technol., vol. 25, no. 6, pp. 798-812, 2020.
[25]
G. Y. Wu, X. Guo, and B. H. Xu. BAM: A block-based Bayesian method for detecting genome-wide associations with multiple diseases, Tsinghua Sci. Technol., vol. 25, no. 5, pp. 678-689, 2020.
[26]
M. Bouazizi and T. Ohtsuki, Multi-class sentiment analysis on twitter: Classification performance and challenges, Big Data Mining and Analytics, vol. 2, no. 3, pp. 181-194, 2019.
[27]
P. J. Rousseeuw, I. Ruts, and J. W. Tukey, The bagplot: A bivariate boxplot, Am. Stat., vol. 53, no. 4, pp. 382-387, 1999.
[28]
M. Goedert and M. G. Spillantini, A century of Alzheimer’s disease, Science, vol. 314, no. 5800, pp. 777-781, 2006.
[29]
R. L. Siegel, K. D. Miller, S. A. Fedewa, D. J. Ahnen, R. G. S. Meester, A. Barzi, and A. Jemal, Colorectal cancer statistics, 2017, CA: A Cancer J. Clin., vol. 67, no. 3, pp. 177-193, 2017.
[30]
C. C. Zhang, L. F. Ma, Y. J. Niu, Z. X. Wang, X. Xu, Y. Li, and Y. C. Yu, Circular RNA in lung cancer research: Biogenesis, functions, and roles, Int.J. Biol. Sci., vol. 16, no. 5, pp. 803-814, 2020.